Chronic Pain and the Endocannabinoid System

The endocannabinoid system is a signalling network your body already runs. It uses two receptors, CB1 and CB2, and two messengers, anandamide and 2-AG, to set how loudly pain signals travel and how strongly inflammation flares. That is why the endocannabinoid system and chronic pain are studied together, and why the honest answer is more careful than the internet suggests.

I want to give you the machinery here, not a promise. If what you actually need today is the practical version, the "I am doing everything right and I am still in pain" version, start with why your pain treatments may not be helping. Then come back and I will show you what is under the hood.

The short version

• The endocannabinoid system is a regulator, not an organ. It is receptors, messenger molecules, and enzymes spread through your nervous system and your immune tissue.
• CB1 and CB2 do different jobs. CB1 is the dominant subtype in the central nervous system, and cannabinoid signalling also acts out at peripheral sites in the body.
• Anandamide and 2-AG are made on demand. Your body does not store them in a tank. It builds them where and when they are needed, then breaks them down quickly.
• The pain link is real science. The National Academies of Sciences, Engineering, and Medicine found substantial evidence that cannabis is effective for the treatment of chronic pain in adults, which is why serious researchers keep working here.
• The CBD evidence is thinner than the marketing. A 2022 systematic review found only short-term benefit for certain products, with real side effects and big gaps in the long-term data.

What is the endocannabinoid system, in plain terms?

Gentle movement can support the body without forcing a fix.

Think of it as your body's volume knob system. Not a single structure you could point to on an anatomy chart, but a set of receptors sitting on cell surfaces, small fatty messenger molecules that switch those receptors on, and enzymes that build and then dismantle the messengers.

It sits alongside your other regulating systems, quietly nudging things toward balance. Nerve signalling. Immune response. Appetite, mood, sleep. It does not do one job. It keeps other jobs from running too hot or too cold.

I explain it this way because the name scares people. "Endocannabinoid" simply means the cannabinoid-like compounds your own body makes, from the inside. The system was named after the plant that led researchers to it, not the other way around. You had it before you ever heard of it.

What do CB1 and CB2 receptors actually do?

The system's effects run mainly through two G-protein coupled receptors, CB1 and CB2, with CB1 the dominant subtype in the central nervous system, and cannabinoid signalling also acting at peripheral sites (International Journal of Molecular Sciences, via NIH).

CB1, the brain and nerve receptor. These sit on nerve cells, densely in the parts of the brain and spinal cord that handle pain processing, movement, memory, and mood. Activating CB1 generally dials down how freely nerve cells fire. It is the receptor most associated with the intoxicating effects of THC, and with pain signal modulation.

CB2, the immune receptor. These show up more on immune cells and in peripheral tissue, and they get more numerous where there is injury or ongoing inflammation. CB2 activity leans toward calming immune signalling rather than changing how you perceive things.

That split is useful but not absolute. Both receptors turn up in more places than the clean summary implies, and their numbers shift with the state of the tissue. That flexibility is part of what makes the system interesting and part of what makes it hard to study.

What are anandamide and 2-AG, and why does your body make them?

An easy walk is often enough for one honest day.

These are your two best-known endocannabinoids, the messengers themselves. Anandamide, whose name comes from a Sanskrit word for bliss, and 2-arachidonoylglycerol, mercifully shortened to 2-AG.

Here is the part I find genuinely elegant. Molecules like insulin or adrenaline are manufactured in advance and stored until released. Endocannabinoids are not stored. They are built from fatty components of the cell membrane at the moment they are needed, released right there, and broken down by enzymes within minutes.

So this is a local, on-demand, short-lived system. Your body is not broadcasting a hormone through the bloodstream. It is having a quiet, targeted conversation between two cells and then ending it.

There is one more twist worth knowing, because it explains the pain connection. Endocannabinoid signalling largely runs backwards, from the receiving neuron back to the sending one. The cell getting the message makes the endocannabinoid and sends it upstream, where it tells the sending cell to ease off. It is a feedback brake built into the wiring.

How does the endocannabinoid system change the way you feel pain?

Pain is not a single wire from an injury to your brain. It is a signal that gets amplified or muted at several checkpoints along the way, and endocannabinoid signalling shows up at more than one of them.

Researchers describe several mechanisms behind cannabinoid pain modulation: inhibiting neurotransmitter and neuropeptide release from presynaptic nerve endings, modulating how excitable the receiving neuron is, activating the descending inhibitory pain pathways that run down from the brain, and reducing neural inflammation (Frontiers in Pharmacology, via NIH).

Translated into plain language, that is three floors of the same building.

• Out at the tissue. Where a nerve ending meets an inflamed or injured area, signalling can quiet how insistently that nerve reports.
• At the spinal cord. The relay station where incoming pain traffic gets passed upward, or does not. This is where that backwards feedback brake matters most.
• From the brain downward. Your brain runs its own pain suppression circuits that reach back down the spinal cord. Endocannabinoid activity is part of what switches those on.

That layered design is exactly why the system draws attention from pain researchers. It is not that it removes pain. It is that it appears to be one of the ways the body sets the gain, and gain is often what has gone wrong for people with long-standing pain. If you live with widespread pain and fatigue, this same theme runs through what I wrote about living well with fibromyalgia.

What does the endocannabinoid system have to do with inflammation?

CB2 is the short answer. Immune cells carry these receptors, and receptor numbers tend to rise in tissue that is inflamed, which reads like the body trying to place more brakes exactly where things are running hot.

Inflammation matters for pain in two directions. Inflammatory chemistry makes nerve endings more sensitive, so the same stimulus reports louder. And ongoing pain signalling itself provokes low-grade inflammation in nervous tissue. Each feeds the other, which is part of why long-standing pain gets so stubborn.

Reducing neural inflammation is listed among the cannabinoid analgesic mechanisms in that same Frontiers in Pharmacology review. I want to be careful with how far I take that. Showing a mechanism exists in tissue is not the same as showing a product helps a person, and the gap between those two things is where most health marketing quietly lives.

Why is this a real area of research and not just internet talk?

Because the most conservative body in American science looked at it. The National Academies of Sciences, Engineering, and Medicine reviewed the evidence and concluded there is substantial evidence that cannabis is effective for the treatment of chronic pain in adults (National Academies, via NIH Bookshelf). "Substantial evidence" is their second-highest tier, and they applied it sparingly across the whole report.

Chronic pain is also the most commonly cited reason people use medical cannabis, per that Frontiers in Pharmacology review. People are already making this decision, often without a clinician in the conversation.

Early in my career I was not permitted to answer questions about any of this. Patients asked anyway. I am glad that has changed, because silence never protected anyone, it just sent people to whatever the loudest website said.

What does the evidence actually say about CBD and chronic pain?

Here I have to slow you down, because the science of the system and the evidence for the products are two different conversations.

A 2022 AHRQ-funded systematic review in the Annals of Internal Medicine pooled 18 randomized placebo-controlled trials with 1,740 participants and 7 cohort studies with 13,095 participants (Annals of Internal Medicine, via PubMed). What the reviewers found was short-term benefit, in the one to six month range, for certain high-THC products and comparable THC-to-CBD products, alongside dizziness and sedation. For other products, and for what happens over longer periods, the evidence was either not reported or judged insufficient.

Read that carefully, because the shape of it is the finding. Short-term. Certain products. Real side effects. Long-term picture unknown.

The regulatory reality is just as plain. The FDA has not approved the cannabis plant for any medical use. The only FDA-approved purified CBD drug, Epidiolex, is approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex, and nothing else. THC or CBD products cannot legally be sold as dietary supplements (National Center for Complementary and Integrative Health, NIH).

So when someone tells you a bottle will handle your pain, they are ahead of the evidence and ahead of the law. I would rather be the nurse who told you that.

Why is CBD product quality such a problem, and what should you look for?

Because the label often is not true. When researchers ran laboratory testing on 80 commercially available hemp-derived CBD products, 37 of them, 46 percent, differed from their stated CBD concentration by more than plus or minus 10 percent. Twelve contained less than 90 percent of the label claim and 25 contained more than 110 percent (Journal of Cannabis Research, via NIH).

NCCIH also warns that over-the-counter CBD products may contain more or less CBD than labelled, plus contaminants including THC. That last one is not a small detail if you are drug tested at work.

If you and your medical team decide to explore this, these are the questions I would want answered before anything is purchased.

• Is there a current certificate of analysis from an independent lab? Not the company's own claim. A third-party report, dated, matching the batch number on your bottle.
• Does the report cover contaminants, not just potency? Pesticides, heavy metals, residual solvents, and THC content should all appear.
• Does the measured amount match the label? Given those testing results, this is not a paranoid question. It is close to a coin flip.
• Is the company making disease claims? If the packaging or website says it treats a condition, that is a company willing to break a rule you can see. Assume it breaks others you cannot.

Can CBD interact with medications you are already taking?

Yes, and this is the part that gets waved away most often. CBD is processed by the same liver enzyme pathways that handle a long list of prescription medications, so it can change how much of a drug ends up in your bloodstream.

A published case report documented a clinically significant interaction between cannabidiol and the blood thinner warfarin, where the patient's INR rose and the warfarin dose had to be reduced (Epilepsy & Behavior Case Reports, via NIH). If you are on warfarin, that is a conversation with your prescriber before anything else happens, not after.

Seizure medications deserve the same caution, along with sedatives, since dizziness and sedation showed up as risks in that Annals review, and those effects stack. Add in anything that already makes you drowsy and you have a fall risk, which for anyone over sixty is not a minor consideration.

This is where my old refrain earns its keep. Start low. Go slow. Monitor closely. And do all three with your medical team watching, not on your own.

A moment from practice: one coaching client's experience with Parkinson's and CBD

I coach a woman living with Parkinson's disease who uses CBD and tells me she has noticed real improvements in how she feels. She brought it to her neurologist and her pharmacist first, they reviewed her full medication list with her, and she has kept them in the loop since. She reports she is glad she tried it.

I want to be completely clear about what that is and what it is not. That is one person's experience. It is an anecdote, not evidence. A single story cannot tell us whether something works, because it cannot separate the product from time, from placebo response, from everything else changing in a life. I am including it because she is real and her experience is hers to have, not because it proves anything.

Please do not read it as a reason to expect the same result. CBD is not an approved treatment for Parkinson's disease, the only FDA-approved CBD medication is Epidiolex, prescribed for seizures associated with certain rare conditions, and what one person notices tells you nothing reliable about what you would notice. If you live with Parkinson's, your movement-disorder team is the right place for this question. I have written more supportive pieces on the daily side of things, including gentle movement for Parkinson's.

What questions should you bring to your prescriber and pharmacist?

Your pharmacist is the most underused expert in your life, and interactions are exactly their specialty. Bring your complete list, prescriptions, over-the-counter items, and supplements, and ask directly.

• Does this interact with anything I take? Especially blood thinners, seizure medications, sedatives, and anything with a narrow safe range.
• Would it change my liver enzyme testing or any monitoring I already do?
• What side effects should make me stop and call you? Dizziness, unusual sleepiness, and anything new after starting.
• If we try it, how would we tell whether it is actually doing anything? Agree on what you are measuring before you start, or you will never know.

That last question is the one I care about most. A plan with no way to evaluate it is not a plan. Bringing this to your doctor rather than around them changes everything, which is the point of working with a health coach alongside your doctor.

Where should you read next if your treatments are not working?

For the lived, practical companion to all this physiology, read why your pain treatments may not be helping. It covers the pain and stress loop and where to start when everything feels stuck. And if pain has your nervous system running hot, how chronic stress affects your body fills in the other half.

A Final Thought

I am not going to tell you that understanding this system will fix your pain. What I will tell you is that your body has a built-in mechanism for turning pain signalling down, that it is real and mapped and taken seriously by serious scientists, and that we do not yet know nearly as much as the marketing pretends about influencing it from the outside.

Knowing where the evidence stops is not a disappointment. It is what lets you make a decision you can stand behind, with your medical team beside you.

If you are carrying long-standing pain and you would like someone to help you sort the real information from the noise, come book a free discovery call with me. No pressure, no pitch, no product to sell you. Just a nurse who will tell you the truth, neighbor to neighbor. And on the harder days, the free guided calming tools in the Sanctuary are always there.

With Care, Cheri Sacks, R.N., B.S.N., C.D.C.E.S., "Your Neighbor, The Nurse"

Related reading

• Why Your Pain Treatments Are Not Helping
• Living Well With Fibromyalgia
• How Chronic Stress Affects Your Body
• Gentle Movement for Parkinson's
• How to Work With a Health Coach and Your Doctor

Images (SEO manifest)

1. Feature image, 16:9 (1600×900)

Filename: endocannabinoid-system-and-chronic-pain-feature.jpg Alt text: Woman in her sixties resting a hand on an aching shoulder in soft morning light Caption: How the endocannabinoid system and chronic pain connect is real physiology, not internet talk. Prompt: Editorial premium-magazine photograph of a real woman in her sixties seated near a large window in a calm home, one hand resting gently on an aching shoulder, a thoughtful and composed expression rather than distress. Authentic and un-posed, a genuine lived-in face, not a stock model. Soft natural side light, shallow depth of field with a creamy blurred background, warm and steady mood. Subtle brand accents carried only as tones through wardrobe, props, and color grade: a deep navy cardigan, a soft teal cushion, warm cream walls, a faint touch of muted gold in the light. Clean negative space on the left. No logos, no signage. no text, no watermark, photorealistic, high resolution.

2. Social / OG image, 1.91:1 (1200×630)

Filename: endocannabinoid-system-and-chronic-pain-og.jpg Alt text: Calm still life with a notebook, reading glasses, and a glass of water on cream linen Caption: What we honestly know about the endocannabinoid system and chronic pain, and where the evidence stops. Prompt: Editorial premium-magazine still-life photograph, wide landscape crop, of an open notebook, reading glasses, and a glass of water on a cream linen table, with a woman's deep-navy sleeve softly out of focus at the edge, suggesting careful reading rather than selling. Authentic and natural, not stock-perfect, soft diffused window light, shallow depth of field with gentle bokeh, calm and credible mood. Brand accents as tones only: deep navy fabric, a soft teal cloth, warm cream surfaces, a faint muted-gold glow. Generous clean negative space to one side for overlay. No logos, no signage. no text, no watermark, photorealistic, high resolution.

3. In-body image A, 16:9 (1200×675), for "How does the endocannabinoid system change the way you feel pain?"

Filename: endocannabinoid-system-and-chronic-pain-signalling.jpg Alt text: Nurse's hands gesturing while explaining how pain signals travel, at a sunlit kitchen table Caption: Receptors, anandamide and 2-AG sit between the endocannabinoid system and chronic pain signalling. Prompt: Editorial premium-magazine photograph of a real nurse in her fifties at a sunlit kitchen table, hands mid-gesture as she explains something patiently to someone just out of frame, a warm and unhurried expression. Authentic and documentary, a real everyday person, not a stock model. Soft natural window light, shallow depth of field with a creamy blurred background, warm and trustworthy mood. Subtle brand accents as tones only: a soft teal blouse, a deep navy chair, warm cream table linen, a faint touch of muted gold in the light. Clean negative space on one side. No logos, no signage. no text, no watermark, photorealistic, high resolution.

4. In-body image B, 16:9 (1200×675), for "Can CBD interact with medications you are already taking?"

Filename: endocannabinoid-system-and-chronic-pain-pharmacist.jpg Alt text: Older woman reviewing her medication list with a pharmacist across a counter Caption: CBD questions belong at the edge of endocannabinoid system and chronic pain research, so ask your pharmacist. Prompt: Editorial premium-magazine photograph of a real woman in her sixties standing at a pharmacy counter reviewing a printed medication list with a pharmacist, both engaged in a calm practical conversation. Authentic and un-posed, real people with lived-in warmth, not stock models. Soft even daylight, shallow depth of field with a gently blurred background, reassuring and professional mood. Subtle brand accents as tones only: a deep navy coat, a soft teal shelf edge, warm cream counter surfaces, a faint muted-gold highlight. Clean negative space on one side. No logos, no signage, no readable labels. no text, no watermark, photorealistic, high resolution.